Autus Asset Management, LLC Abb Vie Inc. Transaction History

Autus Asset Management, LLC

$556 Million
Q4 2022

A detailed history of Autus Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Autus Asset Management, LLC holds 75,934 shares of ABBV stock, worth $13.7 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

75,934

Previous 77,830 2.44%

Holding current value

$13.7 Million

Previous $10.4 Million 17.55%

% of portfolio

2.21%

Previous 2.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$138.31 - $165.87 $262,235 - $314,489	-1,896 Reduced 2.44%	75,934 $0
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $34,223 - $39,252	-255 Reduced 0.33%	77,830 $10.4 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $198,172 - $251,942	-1,440 Reduced 1.81%	78,085 $12 Million
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $2.56 Million - $3.18 Million	-19,413 Reduced 19.62%	79,525 $12.9 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $254,609 - $322,154	2,370 Added 2.45%	98,938 $13.4 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $267,702 - $303,882	2,516 Added 2.68%	96,568 $10.4 Million
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $57,339 - $63,879	545 Added 0.58%	94,052 $10.6 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $238,870 - $262,967	2,335 Added 2.56%	93,507 $10.1 Million
Q4 2020 Jan 19, 2021	SELL	$80.49 - $108.67 $445,914 - $602,031	-5,540 Reduced 5.73%	91,172 $9.77 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $134,191 - $157,496	1,562 Added 1.64%	96,712 $8.47 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $68,307 - $91,405	931 Added 0.99%	95,150 $9.34 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $293,281 - $444,651	4,547 Added 5.07%	94,219 $7.18 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $30,727 - $38,446	426 Added 0.48%	89,672 $7.94 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $248,645 - $298,942	3,948 Added 4.63%	89,246 $6.76 Million
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $485,523 - $620,612	7,390 Added 9.49%	85,298 $6.2 Million
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $4.88 Million - $5.74 Million	63,223 Added 430.53%	77,908 $6.28 Million
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $6,668 - $7,413	-75 Reduced 0.51%	14,685 $1.39 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $57,010 - $67,456	635 Added 4.5%	14,760 $1.37 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $87,409 - $117,049	-950 Reduced 6.3%	14,125 $1.34 Million
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $8,956 - $9,821	-100 Reduced 0.66%	15,075 $1.46 Million
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $6,984 - $8,922	-100 Reduced 0.65%	15,175 $1.35 Million
Q2 2017 Aug 09, 2017	BUY	N/A	15,275	15,275 $1.11 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Autus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autus Asset Management, LLC with notifications on news.

Account

Autus Asset Management, LLC Abb Vie Inc. Transaction History